Raymond James analyst Rahul Sarugaser has identified a biotech stock he thinks can be a winner for i... Read More
It’s been an up-and-down year so far for Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart... Read More
Leede Jones Gable analyst Douglas W. Loe likes the clinical progress being made by Calgary, Alberta-... Read More
With the thought of a Phase III cancer trial on the horizon Leede Jones Gable analyst Douglas W. Loe... Read More
The start of a Phase 2 trial is a key step for Oncolytics Biotech (Oncolytics Biotech Stock Quote, C... Read More
Alberta-based biologics developer Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News TS... Read More
Compared to its oncology drug peers, Canadian cancer biologics developer Oncolytics Biotech (Oncolyt... Read More
Echelon Wealth Partners analyst Douglas Loe says price softness in cancer biologics developer Oncoly... Read More
Echelon Wealth Partners analyst Doug Loe thinks cancer biologics company Oncolytics Biotech (Oncolyt... Read More
Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart TSX:ONC) announced its third quarter finan... Read More
New research results from clinical-stage oncology company Oncolytics Biotech (Oncolytics Biotech Sto... Read More
The end of Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News: TSX:ONC, Nasdaq:ONCY) ph... Read More
New data from Oncolytics Biotech (Oncolytics Stock Quote, Chart, News: TSX:ONC) has Paradigm Capital... Read More
A major milestone for Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News: TSX:ONC) is b... Read More
Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News: TSX:ONC, Nasdaq:ONCY) yesterday ann... Read More
Shares of Oncolytics Biotech (TSX:ONC, Nasdaq:ONCY) are up today after the company announced that th... Read More
The results from Oncolytics’ (Oncolytics Stock Quote, Chart, News: TSX:ONC) U.S. Phase Two pan... Read More
Yesterday, after market close, Oncolytics (TSX:ONC, Nasdaq:ONCY) delivered underwhelming data from a... Read More